Emerging as a significant development in the struggle against obesity, this medication is attracting considerable interest . It combines effects of two established GLP-1 receptor agonists, liraglutide, plus an additional glucose-dependent peptide component. Preliminary patient data have shown significant weight reduction in patients with obesity… Read More